Defending allegations that its popular weed killer Roundup is carcinogenic, agrochemical giant Monsanto has accused the class action of having its āfinger on the scalesā when presenting scientific evidence to the court.
A class action against agrochemical giant Monsanto has told the court that there is āno safe level of exposureā to carcinogens allegedly present in the company’s popular weed killer Roundup.Ā
Glencore-owned Viterra has failed in its bid for High Court leave to challenge a ruling in a 10-year battle with Cargill over the 2013 sale of malt producer Joe White, leaving the grain producer to fork over damages of almost $300 million.
Monsanto can’t throw out the evidence of an expert for the plaintiff in a class action over its Roundup product who has testified that the company engaged in criminal conduct in trying to bury scientific reports on the popular weed killer’s alleged cancer-causing properties.
On the first day of a seven-week trial, the applicant in a class action against Monsanto has taken aim at the agrochemical giantās āsame old approachā to undermining decades of evidence it says demonstrates the cancer-causing properties of popular weed killer Roundup.
Agrochemical giant Monsanto is digging in for a fight in a class action over its alleged carcinogenic weed killer, Roundup, having refused to budge in mediation despite a $16 billion settlement in the US.
Glencore-owned Viterra has taken its 10-year fight with Cargill to the High Court after an appeals court upheld a judgment putting it on the hook for almost $300 million in damages for misleading representations in the sale of malt producer Joe White in 2013.
In a decade-old dispute, Viterra has lost an appeal of a judgment holding it liable to pay Cargill Australia $293 million for misrepresentations about the performance of its malt producer Joe White, which it sold to Cargill for $420 million in 2013.
The judge overseeing a class action against Monsanto over its weed killer has rejected the agrochemical giant’s application to amend the common questions to be decided at a liability trial to account for its alternative defence.
A judge overseeing two 7-Eleven class actions has signed off on $2.25 million in costs incurred by the funder and lawyers in their pitched battle to win approval for the terms of a $98 million settlement, which included deductions of more than $44 million to cover commission and fees.